Loading resource…

Mayo Clinic
This manual provides detailed guidance on managing cardiovascular issues in cancer patients, particularly those undergoing cardiotoxic therapies. It includes diagnostic criteria, monitoring strategies for conditions like Takotsubo syndrome, and approaches to preventing and managing venous thromboembolism (VTE) in cancer survivors. The content emphasizes risk stratification and tailored management plans based on patient and tumor-specific factors.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Cost Effective Heart Failure Care - St. Mary's Lacor
Same clinical topic · Cardiology

The Heart-Brain Connection
Same clinical topic · Cardiology

Cardiology in the ER: A Practical Guide
Same clinical topic · Cardiology

NITROGLYCERIN (GLYCERYL TRINITRATE): DRUG INFORMATION
Same clinical topic · Cardiology

CLOPIDOGREL: DRUG INFORMATION
Same clinical topic · Cardiology

SACUBITRIL AND VALSARTAN: DRUG INFORMATION
Same clinical topic · Cardiology

CRITERIA FOR THE DIAGNOSIS OF CARDIOGENIC SHOCK—EUROPEAN PERSPECTIVE: A CLINICAL CONSENSUS STATEMENT
Same specialty · Cardiology

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Same specialty · Cardiology

2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure
Same specialty · Cardiology